Disclaimer
The alfapump® system is not currently approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see www.poseidonstudy.com.
The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed.
The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the alfapump® system in Europe.
Sequana Medical NV
Kortrijksesteenweg 1112
9051 Sint-Denijs-Westrem
Belgium
+32 9 298 2828
sequanamedical.com
Sequana Medical NV
Technoparkstrasse 1
Building Darwin, 2nd floor
8005 Zurich
+41 44 403 55 00
sequanamedical.com
Sequana Medical GmbH
Rundfunkplatz 2
80335 München
+49 89 38 03 84 05
sequanamedical.com
For enquiries or to request information material, please use our contact form below. You will be contacted as soon as possible by our expert.